Kathryn McCauley

Kathryn McCauley

Auto-generated profile, based on publicly available information

Kathryn McCauley

Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
WFWendy Fonseca
Wendy Fonseca
CMCarrie Malinczak
Carrie Malinczak
KFKei Fujimura
Kei Fujimura
DLDanny Li
Danny Li
KMKathryn McCauley
Kathryn McCauley
CPCatherine Ptaschinski
Catherine Ptaschinski
Development of the immune system can be influenced by diverse extrinsic and intrinsic factors that influence the risk of disease. Severe early life respiratory syncytial virus (RSV) infection is associated with persistent immune alterations. Previously, our group had shown that adult mice orally supplemented with Lactobacillus johnsonii exhibited decreased airway immunopathology following RSV infection. Here, we demonstrate that offspring of mice supplemented with L. johnsonii exhibit reduced airway mucus and Th2 cell–mediated response to RSV infection. Maternal supplementation resulted in a consistent gut microbiome in mothers and their offspring. Importantly, supplemented maternal plasma and breastmilk, and offspring plasma, exhibited decreased inflammatory metabolites. Cross-fostering studies showed that prenatal Lactobacillus exposure led to decreased Th2 cytokines and lung inflammation following RSV infection, while postnatal Lactobacillus exposure diminished goblet cell hypertrophy and mucus production in the lung in response to airway infection. These studies demonstrate that Lactobacillus modulation of the maternal microbiome and associated metabolic reprogramming enhance airway protection against RSV in neonates.

28 July 2022 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
KRKathryn J. Ray
Kathryn J. Ray
CSClark Santee
Clark Santee
KMKathryn McCauley
Kathryn McCauley
APAriane R. Panzer
Ariane R. Panzer
SLSusan V. Lynch
Susan V. Lynch
Background: Relationships between gut microbiomes and airway immunity have been established in murine and human studies of allergy and asthma. Early life Lactobacillus supplementation alters the composition and metabolic productivity of the gut microbiome. However, little is known of how Lactobacillus supplementation impacts the gut microbiota in children with cystic fibrosis (CF) and whether specific microbiota states that arise following gut microbiome manipulation relate to pulmonary outcomes. Methods: Stool samples were collected from CF patients enrolled in a multi-center, double-blind, randomized placebo-controlled trial of daily Lactobacillus rhamnosus strain GG (LGG) probiotic supplementation over a 12-month period. Fecal 16S rRNA biomarker sequencing was used to profile fecal bacterial microbiota and analyses were performed in QiiME. Results: Bifidobacteria-dominated fecal microbiota were more likely to arise in LGG-treated children with CF (P = 0.04). Children with Bifidobacteria-dominated gut microbiota had a reduced rate of pulmonary exacerbations (IRR = 0.55; 95% CI 0.25 to 0.82; P = 0.01), improved pulmonary function (+ 20.00% of predicted value FEV1; 95% CI 8.05 to 31.92; P = 0.001), lower intestinal inflammation (Calprotectin; Coef = − 16.53 μg g−1 feces; 95% CI − 26.80 to − 6.26; P = 0.002) and required fewer antibiotics (IRR = 0.43; 95% CI 0.22 to 0.69; P = 0.04) compared to children with Bacteroides-dominated microbiota who were less likely to have received LGG. Conclusions: The majority of pediatric CF patients in this study possessed a Bacteroides- or Bifidobacteria-dominated gut microbiota. Bifidobacteria-dominated gut microbiota were more likely to be associated with LGG-supplementation and with better clinical outcomes.

1 February 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
KMKathryn McCauley
Kathryn McCauley
JDJuliana Durack
Juliana Durack
DFDouglas Fadrosh
Douglas Fadrosh
KLKole Lynch
Kole Lynch
APAriane Panzer
Ariane Panzer
SLSusan V. Lynch
Susan V. Lynch

15 April 2013 in Cancer Research
Verified
Journal Article
Closed access
CMCatherine Metayer
Catherine Metayer
EMElizabeth Milne
Elizabeth Milne
JDJohn D. Dockerty
John D. Dockerty
JCJacqueline Clavel
Jacqueline Clavel
MPMaria S. Pombo-De-Oliveira
Maria S. Pombo-De-Oliveira
CIClaire Infante-Rivard
Claire Infante-Rivard
Background: Acute leukemia is the most common cancer in children under 15 years of age; 80% are acute lymphoblastic leukemias (ALL) and 17% acute myeloid leukemias (AML). The early onset of the disease is suggestive of genetic predisposition and critical exposures occurring before birth. Maternal prenatal supplementation with folic acid and other vitamins, known to maintain DNA integrity and limit oxidative stress, could play a role in the prevention of childhood leukemia. However, reduced risks of childhood ALL following prenatal supplementation have been reported inconsistently. As for childhood AML, a rarer subtype, little is known regarding the effect of prenatal vitamins. Methods: We pooled original data on socio-demographic characteristics and maternal intake of folic acid, vitamins, and alcohol from 12 case-control studies (1980-2012) participating in CLIC (clic.berkeley.edu). The standardized data included the use of any vitamins, and use of folic acid, given anytime (before and/or during pregnancy) or during a specific period. The pooled analyses included 6,970 cases of ALL, 585 cases of AML, and 19,617 controls. Subgroup analyses were undertaken for vitamin type, period of use, and leukemia subtype. Logistic regression was used to estimate the odds ratios (OR) and 95 % confidence interval (CI), adjusted for age, sex, ethnicity, and other confounders including parental education, and study center. Results: Maternal intake of vitamins and folic acid anytime prenatally was associated with reduced risks of childhood ALL and AML. For ALL, the ORs for vitamin and folic acid intake during pregnancy specifically were 0.78 (95% CI: 0.71-0.85) and 0.82 (95% CI: 0.72-0.94), respectively, and 0.85 (95% CI: 0.64-1.13) and 0.52 (95% CI: 0.31-0.88), respectively, for AML. The observed reduction in ALL risk associated with prenatal vitamin intake was stronger in households where parents had no formal education or a primary education (OR=0.68, 95% CI: 0.56-0.83) and a secondary education (OR=0.75, 95% CI: 0.66-0.85), compared to those with a tertiary education (OR=0.96, 95% CI: 0.86-1.09). A similar trend across education levels was reported for maternal folic acid intake. The association between childhood ALL and maternal vitamin and folic acid intake also appeared stronger among women who did not consume alcohol. Conclusions: Our analyses based on the largest number of childhood ALL and AML cases to date suggest that maternal vitamin and folic acid intake reduces the risk of acute childhood leukemias. The risk seems modified by surrogate markers of nutritional status such as socio-economic status and alcohol consumption. Alternatively, participant selection, recall, access to prenatal care, or genetic susceptibility may vary in low vs. high income populations, therefore possibly contributing to this observation.


7 May 2026 in Microbiology Resource Announcements
Verified
Journal Article
Closed access
LKLauren E. Krausfeldt
Lauren E. Krausfeldt
PSPoorani Subramanian
Poorani Subramanian
DDDuc Doan
Duc Doan
KMKathryn McCauley
Kathryn McCauley
MDMichael Dolan
Michael Dolan
DHDarrell Eugene Hurt
Darrell Eugene Hurt
DiscoVir is an automated pipeline for viral metagenomics available in National Institute of Allergy and Infectious Diseases (NIAID)’s free web application for microbiome analysis, Nephele. DiscoVir makes viral discovery, taxonomic and functional annotation, host predictions, and diversity analyses of the virome easily accessible to researchers at all levels of expertise.